Back
Fulcrum Therapeutics, Inc. Stock Predictions
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
48
FULC
Fulcrum Therapeutics, Inc.
Last Price:
$8.76
Seasonality Move:
23.58%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiFulcrum Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Fulcrum Therapeutics, Inc. has on average historically risen by 8.1% based on the past 6 years of stock performance.
-
Fulcrum Therapeutics, Inc. has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Fulcrum Therapeutics, Inc. Stock Undervalued?The current Fulcrum Therapeutics, Inc. [FULC] share price is $8.76. The Score for FULC is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
FULC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Fulcrum Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Fulcrum Therapeutics, Inc. has on average historically risen by 8.1% based on the past 6 years of stock performance.
Fulcrum Therapeutics, Inc. Stock Rating
Sell
48
Fulcrum Therapeutics, Inc. (FULC)
is a Sell
Is Fulcrum Therapeutics, Inc. overpriced?
-
Fulcrum Therapeutics, Inc. has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Fulcrum Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
fulcrumtx.com
52-Week Data
52-Week High:
12.19
52-Week Low:
2.32
Prediction Charts
Market Cap:
474.1M
Price in USD:
8.76
Volume:
821.2K
Beta:
2.40
Technical Analysis
SMA50:
9.31
SMA100:
8.18
SMA200:
6.58
52-Wk Change:
149.57%
Stock Predictions
-
Is Fulcrum Therapeutics, Inc. stock public?Yes, Fulcrum Therapeutics, Inc. is a publicly traded company.
-
What is the Fulcrum Therapeutics, Inc. stock quote today?The Fulcrum Therapeutics, Inc. stock price is 8.76 USD today.
-
How to buy Fulcrum Therapeutics, Inc. stock online?You can buy Fulcrum Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 8.69 | 8.65 | 8.96 | 8.43 |
| Nov-17 | 8.67 | 9.65 | 9.75 | 8.46 |
| Nov-18 | 9.52 | 9.73 | 9.85 | 9.03 |
| Nov-19 | 10.65 | 11.51 | 12.19 | 10.45 |
| Nov-20 | 11.71 | 11.06 | 11.81 | 10.98 |
| Nov-21 | 11.00 | 11.29 | 11.32 | 10.75 |
| Nov-24 | 11.73 | 11.74 | 12.05 | 11.40 |
| Nov-25 | 11.77 | 11.54 | 11.99 | 11.50 |
| Nov-26 | 11.52 | 11.32 | 11.66 | 11.13 |
| Nov-28 | 11.33 | 10.94 | 11.46 | 10.50 |
| Dec-1 | 10.78 | 9.87 | 10.94 | 9.77 |
| Dec-2 | 9.92 | 8.95 | 10.22 | 8.74 |
| Dec-3 | 8.92 | 9.06 | 9.68 | 8.73 |
| Dec-4 | 8.95 | 8.76 | 9.29 | 8.68 |
Fulcrum Therapeutics, Inc. Earnings
Fulcrum Therapeutics, Inc. Earnings Report: Per Share Fulcrum Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Fulcrum Therapeutics, Inc. Forecast Revenue Growth
Fulcrum Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Fulcrum Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.04 per share, and a decrease next year of $0.04 per share.
* Fulcrum Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.